Close
Nordic 9Nordic 9

Amolyt Pharma (private company)

France amolytpharma.com
See something wrong or missing? Let us know
Offices:Lyon
Industry:Health servicesPharma
Business model:B2B

Amolyt Pharma is a French developer of therapeutic peptides for rare endocrine diseases

Investors: we tracked 1 investor

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 139.66MSecondary 1.05B

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Amolyt Pharma

Name Criteria
Spain Ability Pharma
57%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
France AbolerIS Pharma
57%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 4
  • Total raised in a similar range: 10M+ USD
Denmark Acesion Pharma
57%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom Beckley Psytech
57%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 4
  • Total raised in a similar range: 10M+ USD
Spain Bigfinite
57%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Finland Forendo Pharma
57%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 5
  • Total raised in a similar range: 10M+ USD
Denmark NMD Pharma
57%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Spain Ona Therapeutics
57%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Spain Sanifit Therapeutics
57%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 4
  • Total raised in a similar range: 10M+ USD
France Synapse Medicine
57%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Top